GlyTherix Ltd is pleased to announce Alan Harris MD PhD has taken an expanded role as a Strategic and Scientific Advisor to assist the company increase its current US footprint including retention of key US-based personnel. He will work closely with GlyTherix’s Dr Gabriel Liberatore (former Telix Pharmaceuticals Limited Group COO) to build out US capability in supply chain and manufacturing for our novel cancer therapy. This is an exciting step forward in establishing an even stronger US presence for the company.